-
公开(公告)号:US20240389591A1
公开(公告)日:2024-11-28
申请号:US18685970
申请日:2022-08-19
Applicant: BASF SE
Inventor: Rahul Kaduskar , Martin Viertelhaus , Sunil Kolse , Desislava Slavcheva Petkova , Tobias Seiser , Roland Goetz , Harish Shinde , Henning Urch , Ricardo Hugo Pavon Romero
IPC: A01N43/54 , A01N25/04 , A01P13/00 , C07D239/54
Abstract: The present invention relates to one crystalline form A of methyl 2-[2-[2-bromo-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy]phenoxy]-2-methoxy-acetate, a process for the production of this crystalline form and formulations for plant protection comprising such form A.
-
公开(公告)号:US10045998B2
公开(公告)日:2018-08-14
申请号:US15103146
申请日:2014-12-09
Applicant: BASF SE
Inventor: Tiziana Chiodo , Beate Salvador , Marcus Vossen , Andreas Hafner , Tobias Hintermann , Martin Szelagiewicz , Fritz Blatter , Martin Viertelhaus , Walter Weishaar
Abstract: Combinations of (3β)-17-(pyridin-3-yl)androsta-5,16-dien-3-yl acetate (Abiraterone acetate) with acidic substances such as citric acid, ascorbic acid, methyl-4-hydroxy benzoate, saccharin, vanillic acid, adipic acid, maleic acid, malic acid, tartaric acid are useful as pharmaceutical preparations and show improved properties such as aqueous solubility and dissolution kinetics, especially in the form of cocrystals or their combination with a suitable acid.
-
公开(公告)号:US11897847B2
公开(公告)日:2024-02-13
申请号:US17058709
申请日:2019-05-29
Applicant: BASF SE
Inventor: Martin Viertelhaus , Rolf Hellmann , Tobias Seiser , Cyrill Zagar , Gregory Armel , Ulrich Steinbrenner
IPC: C07D239/54 , A01N43/54
CPC classification number: C07D239/54 , A01N43/54 , C07B2200/13
Abstract: The present invention relates to one crystalline form A of ethyl 2-[2-[2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy]phenoxy]acetate, a process for the production of this crystalline form, formulations for plant protection and herbicidal compositions comprising such form A.
-
公开(公告)号:US11685759B2
公开(公告)日:2023-06-27
申请号:US17286474
申请日:2019-10-17
Applicant: BASF SE
Inventor: Michael Puhl , Sebastian Wloch , Peter Oedman , Anne-Catrin Letzel , Hartwig Schroeder , Jacek Malisz , Daniel Seibert-Ludwig , Emiel Jan Kappert , Chung Huan Wong , Michael Barros Gross , Martin Viertelhaus
CPC classification number: C07H1/08 , C07H3/06 , C07B2200/13
Abstract: The present invention relates to a method for obtaining crystalline 2′-fucosyllactose from a 2′-FL raw material, which contains 2′-FL as a main constituent and at least 0.5% by weight, frequently at least 1% by weight, in particular at least 2% by weight, more particularly at least 5% by weight, and especially at least 8% by weight,based on the total amount of mono-and oligosaccharides in the raw material, of one or more mono- or oligosaccharides different from 2′-FL, where the method comprises a)providing a solution of the 2′-FL raw material in water, which does not contain more than 10% by weight, preferably not more than 7% by weight, more preferably not more than 5% by weight of organic solvents, based on the total amount of water; b) effecting the crystallization of 2′-FL from the solution provided in step a) by inducing conditions of a controlled super saturation in the solution; and c) separating crystalline 2′-FL from the mother liquor, and where during controlled supersaturation in step b) not more than 10% by weight, preferably not more than 7% by weight, more preferably not more than 5% by weight of organic solvents are present, based on the total amount of water present during step b).
-
公开(公告)号:US11292784B2
公开(公告)日:2022-04-05
申请号:US16764432
申请日:2018-11-08
Applicant: BASF SE
Inventor: Martin Viertelhaus , Rolf Hellmann , Dennis Koulelis , Tobias Seiser
IPC: C07D401/14
Abstract: The present invention relates to crystalline forms of ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy]-2-pyridyl]oxy]acetate, herein after also referred to as “compound of formula (I)”. The invention also relates to a process for the production of these crystalline forms, formulations for plant protection and herbicidal compositions which contain one of these crystalline forms.
-
公开(公告)号:US11311014B2
公开(公告)日:2022-04-26
申请号:US16497938
申请日:2018-03-27
Applicant: BASF SE
Inventor: Martin Viertelhaus , Dennis Koulelis , Tobias Seiser , Cyrill Zagar , Gregory Armel , Ulrich Steinbrenner , Liliana Parra Rapado , Saskia Paehler , Laetitia Souillart
IPC: A01N25/14 , A01N25/32 , A01N43/54 , A01N61/00 , C07D401/12
Abstract: The present invention relates to crystalline forms of ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate (CAS 353292-31-6), herein after also referred to as “compound of formula (I)”.
The invention also relates to a process for the production of these crystalline forms, formulations for plant protection and herbicidal compositions which contain one of these crystalline forms.-
7.
公开(公告)号:US20220024898A1
公开(公告)日:2022-01-27
申请号:US17311403
申请日:2020-01-10
Applicant: BASF SE
Inventor: Joachim Gebhardt , Martin Viertelhaus , Tiziana Chiodo , Michael Rack , Eric George Klauber , Wen Xu , Roland Goetz , Florian Vogt , Birgit Gockel , Sebastian Soergel
IPC: C07D403/12 , A01N43/58 , A01P7/04
Abstract: The present invention relates to a novel crystalline form of 1-(1,2-dimethylpropyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide recently assigned the common name dimpropyridaz. The invention also relates to the use of the crystalline form B for combating invertebrate pests and to formulations for plant protection which contain the crystalline form B of 1-(1,2-dimethylpropyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide. The crystalline form B according to the present invention can be identified by powder X-ray diffractometry on the basis of its powder X-ray diffraction diagram, hereinafter also termed powder X-ray diffraction pattern or PXRD pattern, of the polymorph form B recorded using Cu—Kα radiation (1.54178 Å) at 25° C. displays the 3 following reflections, quoted as 2θ values: 20.69±0.10°, 24.15±0.10° and 30.52±0.10°. In addition to these 3 reflections, the polymorph B of the present invention may display in such a PXRD pattern one or more, in particular at least 2, often at least 4, in particular at least 6 or at least 8 reflections and especially all of the reflections quoted hereinafter as 2θ values: 7.99±0.10°, 10.07±0.10°, 12.38±0.10°, 15.31±0.10°, 15.97±0.10°, 16.50±0.10°, 18.03±0.10°, 19.29±0.10°, 20.22±0.0.10°, 20.96±0.10°, 23.40±0.10°, 23.70±0.10°, 26.09±0.10°, 27.26±0.10° and 32.91±0.10°.
-
公开(公告)号:US20210206729A1
公开(公告)日:2021-07-08
申请号:US17058709
申请日:2019-05-29
Applicant: BASF SE
Inventor: Martin Viertelhaus , Rolf Hellmann , Tobias Seiser , Cyrill Zagar , Gregory Armel , Ulrich Steinbrenner
IPC: C07D239/54 , A01N43/54
Abstract: The present invention relates to one crystalline form A of ethyl 2-[2-[2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy]phenoxy]acetate, a process for the production of this crystalline form, formulations for plant protection and herbicidal compositions comprising such form A.
-
公开(公告)号:US10105355B2
公开(公告)日:2018-10-23
申请号:US15501908
申请日:2015-08-03
Applicant: BASF SE
Inventor: Martin Viertelhaus , Tiziana Chiodo , Beate Salvador , Marcus Vossen , Andreas Hafner , Tobias Hintermann , Walter Weishaar , Rolf Hellmann
IPC: C07D213/40 , A61K31/4402
Abstract: The present invention primarily relates to multi-component crystals comprising a compound of formula 1 and a second compound selected from the group consisting of co-crystal formers and solvents. The invention is further related to pharmaceutical compositions comprising such multi-component crystals. Furthermore, the invention relates to processes for preparing said multi-component crystals. The invention also relates to several aspects of using said multi-component crystals or pharmaceutical compositions to treat a disease.
-
-
-
-
-
-
-
-